Altuvoct

efanesoctocog alfa · Swedish Orphan Biovitrum AB (publ)

Drug timelines are a Plus or Pro feature.

3 regulatory and trial events tracked for Altuvoct, covering 2025-12-19 to 2026-07-08. Get the full timeline:

Most recent: EMA Authorised: Altuvoct (Efanesoctocog alfa) — Swedish Orphan Biovitrum AB (publ)